Such inhibitors would also be highly valuable molecular probes for further investigation of PIN1 regulation of NRF2 in the cellular context, and potentially pave the way for drug molecules that specifically inhibit the cytoprotective effects of NRF2 in cancer. This evidence concerns the gene NFE2L2 and cancer.